Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Correction

Zenith Drugs Results Correction

Zenith Drugs re-submitted its FY26 financial results to correct a Rs. 1.60 Crore tax provision misclassification. The correction is administrative and does not impact reported profits.

Key figures
Value₹1.60 Cr
Source

NSE filing, NSE: ZENITHDRUG. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Zenith Drugs Ltd: key numbers

Share price
₹37.00
Market cap
₹63.45 Cr
Revenue (annual)
₹171.2 Cr
Net profit (annual)
₹3.94 Cr
P/E (TTM)
16.1×Sector 46.1×
Promoter holding
69.98%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zenith Drugs Ltd

All →

Other results correction announcements

All →